SNG Pasadena Dialysis Center Lp is a medicare approved dialysis facility center in Pasadena, Texas and it has 12 dialysis stations. It is located in Harris county at 5040 Crenshaw Road, Pasadena, TX, 77505. You can reach out to the office of SNG Pasadena Dialysis Center Lp at (832) 703-0450. This dialysis clinic is managed and/or owned by Sankar Nephrology Group. SNG Pasadena Dialysis Center Lp has the following ownership type - Profit. It was first certified by medicare in August, 2017. The medicare id for this facility is 452924 and it accepts patients under medicare ESRD program.
| Name | SNG Pasadena Dialysis Center Lp |
|---|---|
| Location | 5040 Crenshaw Road, Pasadena, Texas |
| No. of Dialysis Stations | 12 |
| Medicare ID | 452924 |
| Managed By | Sankar Nephrology Group |
| Ownership Type | Profit |
| Late Shifts | No |
| 5040 Crenshaw Road, Pasadena, Texas, 77505 | |
| (832) 703-0450 | |
| Not Available |
News Archive
Corticosteroid anti-inflammatory drugs have been applied to COVID-19 patients over the course of the pandemic, though the results are mixed. In a recent study, the outcomes for such patients are collated, demonstrating a striking correlation between the development of autoantibodies and mortality.
Researchers at Case Western Reserve University School of Medicine have identified a genetic factor that prevents blockages from forming in blood vessels, a discovery that could lead to new therapies for cardiovascular diseases.
MedDay, a biotechnology company focused on the treatment of nervous system disorders, reports additional positive data from its pivotal Phase III clinical trial, MS-SPI, with MD1003, a highly-concentrated pharmaceutical grade biotin, in patients with Progressive Multiple Sclerosis.
In the northern hemisphere, being born in May is linked to an increased risk of developing multiple sclerosis later in life, while being born in November carries the lowest risk, finds a new study published on bmj.com today.
The bill, introduced in Congress, would also direct the Food and Drug Administration to train state regulators - whose oversights may have contributed to the meningitis outbreak that sickened more than 500 and killed at least 36.
› Verified 5 days ago
| NPI Number | 1073069811 |
| Doing Business As | Sng - Pasadena Dialysis Center Lp |
| Address | 5040 Crenshaw Rd Pasadena, Texas, 77505 |
| Phone Number | (832) 703-0450 |
News Archive
Corticosteroid anti-inflammatory drugs have been applied to COVID-19 patients over the course of the pandemic, though the results are mixed. In a recent study, the outcomes for such patients are collated, demonstrating a striking correlation between the development of autoantibodies and mortality.
Researchers at Case Western Reserve University School of Medicine have identified a genetic factor that prevents blockages from forming in blood vessels, a discovery that could lead to new therapies for cardiovascular diseases.
MedDay, a biotechnology company focused on the treatment of nervous system disorders, reports additional positive data from its pivotal Phase III clinical trial, MS-SPI, with MD1003, a highly-concentrated pharmaceutical grade biotin, in patients with Progressive Multiple Sclerosis.
In the northern hemisphere, being born in May is linked to an increased risk of developing multiple sclerosis later in life, while being born in November carries the lowest risk, finds a new study published on bmj.com today.
The bill, introduced in Congress, would also direct the Food and Drug Administration to train state regulators - whose oversights may have contributed to the meningitis outbreak that sickened more than 500 and killed at least 36.
› Verified 5 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.